Fields »
ABOUT
HELP
BLOG

1620 GENES FOUND

Show / hide columns

XML | RDF | TSV | Page of 33 | next »

Gene

 

 

Gene description

x

 

 

Protein class

x

 

 

 

 

Tissue

Cell

Pathology

 

 

 

 

 

 

Subcellular location

x

Prognostic p-value

x

 

RNA tissue category

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 
B4GALNT3Beta-1,4-N-acetyl-galactosaminyl transferase 3Enzymes
Predicted intracellular proteins
Predicted secreted proteins
Golgi apparatus
Vesicles		Endometrial cancer: 1.69e-10
Tissue enhanced
P2RX4Purinergic receptor P2X, ligand gated ion channel, 4Predicted membrane proteins
Transporters
Actin filaments
Cytosol		Endometrial cancer: 6.30e-10
Mixed
L1CAML1 cell adhesion moleculeCD markers
Disease related genes
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Nucleoplasm
Plasma membrane		Endometrial cancer: 8.51e-10
Lung cancer: 2.36e-6
Renal cancer: 1.17e-4
Head and neck cancer: 3.81e-4
Tissue enhanced
MBOAT2Membrane bound O-acyltransferase domain containing 2Enzymes
Predicted membrane proteins
VesiclesEndometrial cancer: 2.13e-9
Urothelial cancer: 5.32e-4
Tissue enhanced
HIF3AHypoxia inducible factor 3, alpha subunitPredicted intracellular proteins
Transcription factors
Nucleoplasm
Plasma membrane
Cytosol		Endometrial cancer: 6.90e-9
Tissue enhanced
ASS1Argininosuccinate synthase 1Disease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
Nucleoplasm
Cytosol		Endometrial cancer: 8.14e-9
Tissue enhanced
PTX3Pentraxin 3, longPlasma proteins
Predicted secreted proteins
Endometrial cancer: 8.35e-9
Lung cancer: 8.75e-6
Head and neck cancer: 6.36e-4
Tissue enhanced
SPDEFSAM pointed domain containing ETS transcription factorPredicted intracellular proteins
Transcription factors
Nucleus
Nucleoli		Endometrial cancer: 9.26e-9
Tissue enhanced
SCGB2A1Secretoglobin, family 2A, member 1Cancer-related genes
Predicted secreted proteins
Endometrial cancer: 1.54e-8
Colorectal cancer: 1.22e-4
Renal cancer: 6.36e-4
Group enriched
DHRS7BDehydrogenase/reductase (SDR family) member 7BPredicted intracellular proteins
Predicted membrane proteins
Plasma membrane
Cell Junctions
Cytosol		Endometrial cancer: 1.98e-8
Renal cancer: 3.95e-5
Expressed in all
PLPP2Phospholipid phosphatase 2Enzymes
Predicted membrane proteins
MitochondriaEndometrial cancer: 3.21e-8
Breast cancer: 4.55e-4
Tissue enhanced
NXNL2Nucleoredoxin-like 2Predicted intracellular proteins
CytosolEndometrial cancer: 3.83e-8
Breast cancer: 6.53e-4
Renal cancer: 9.60e-4
Mixed
FAM110BFamily with sequence similarity 110, member BPredicted intracellular proteins
Mitochondria
Cytosol		Endometrial cancer: 3.88e-8
Renal cancer: 4.31e-8
Pancreatic cancer: 1.44e-4
Tissue enhanced
IGSF1Immunoglobulin superfamily, member 1Disease related genes
Predicted membrane proteins
Predicted secreted proteins
CytosolEndometrial cancer: 4.25e-8
Tissue enhanced
SMDT1Single-pass membrane protein with aspartate-rich tail 1Predicted membrane proteins
Transporters
Nucleus
Mitochondria		Renal cancer: 2.36e-9
Endometrial cancer: 5.32e-8
Pancreatic cancer: 5.87e-4
Expressed in all
SLC47A1Solute carrier family 47 (multidrug and toxin extrusion), member 1Predicted membrane proteins
Transporters
Endometrial cancer: 5.54e-8
Renal cancer: 1.06e-5
Lung cancer: 1.88e-5
Tissue enhanced
HEXAHexosaminidase A (alpha polypeptide)Candidate cardiovascular disease genes
Disease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted secreted proteins
Endometrial cancer: 5.63e-8
Expressed in all
PGRProgesterone receptorCancer-related genes
FDA approved drug targets
Nuclear receptors
Predicted intracellular proteins
Transcription factors
Endometrial cancer: 5.76e-8
Group enriched
STX18Syntaxin 18Predicted intracellular proteins
Predicted membrane proteins
Plasma membraneEndometrial cancer: 6.33e-8
Colorectal cancer: 2.84e-4
Urothelial cancer: 4.69e-4
Renal cancer: 7.03e-4
Expressed in all
ATPIF1ATPase inhibitory factor 1Predicted intracellular proteins
MitochondriaEndometrial cancer: 6.38e-8
Ovarian cancer: 8.20e-4
Expressed in all
MGAT4AMannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme AEnzymes
Predicted intracellular proteins
Predicted secreted proteins
Golgi apparatusEndometrial cancer: 6.48e-8
Breast cancer: 4.30e-4
Mixed
DRAM1DNA-damage regulated autophagy modulator 1Predicted intracellular proteins
Predicted membrane proteins
Endometrial cancer: 6.52e-8
Renal cancer: 3.91e-4
Expressed in all
KHKKetohexokinase (fructokinase)Disease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
CytosolEndometrial cancer: 7.62e-8
Group enriched
MARK4MAP/microtubule affinity-regulating kinase 4Enzymes
Predicted intracellular proteins
Predicted membrane proteins
CytosolEndometrial cancer: 8.31e-8
Head and neck cancer: 3.05e-5
Expressed in all
GPRIN2G protein regulated inducer of neurite outgrowth 2Predicted intracellular proteins
NucleoplasmEndometrial cancer: 8.60e-8
Head and neck cancer: 3.47e-4
Tissue enhanced
ERBB2Erb-b2 receptor tyrosine kinase 2Cancer-related genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Plasma membrane
Cytosol		Renal cancer: 2.41e-14
Endometrial cancer: 8.99e-8
Pancreatic cancer: 9.17e-4
Expressed in all
SPAG4Sperm associated antigen 4Predicted intracellular proteins
Predicted membrane proteins
Endometrial cancer: 9.52e-8
Colorectal cancer: 1.09e-5
Glioma: 8.89e-5
Renal cancer: 1.28e-4
Urothelial cancer: 6.66e-4
Mixed
SCGB2A2Secretoglobin, family 2A, member 2Cancer-related genes
Predicted secreted proteins
Endometrial cancer: 9.57e-8
Tissue enriched
ZAP70Zeta-chain (TCR) associated protein kinase 70kDaDisease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
RAS pathway related proteins
Renal cancer: 3.02e-8
Endometrial cancer: 9.66e-8
Head and neck cancer: 3.93e-6
Cervical cancer: 6.89e-5
Tissue enhanced
GPR108G protein-coupled receptor 108Predicted intracellular proteins
Predicted membrane proteins
Golgi apparatus
Vesicles		Renal cancer: 1.29e-9
Endometrial cancer: 1.04e-7
Expressed in all
LMO3LIM domain only 3 (rhombotin-like 2)Predicted intracellular proteins
Endometrial cancer: 1.10e-7
Tissue enhanced
DAGLADiacylglycerol lipase, alphaDisease related genes
Predicted membrane proteins
Endometrial cancer: 1.13e-7
Tissue enriched
ADAAdenosine deaminaseDisease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Renal cancer: 2.94e-14
Endometrial cancer: 1.23e-7
Liver cancer: 6.77e-5
Lung cancer: 2.20e-4
Tissue enriched
MAP1LC3CMicrotubule-associated protein 1 light chain 3 gammaPredicted intracellular proteins
Cytoplasmic bodiesEndometrial cancer: 1.34e-7
Tissue enhanced
MSX1Msh homeobox 1Disease related genes
Predicted intracellular proteins
Transcription factors
NucleoplasmEndometrial cancer: 1.64e-7
Renal cancer: 1.18e-5
Group enriched
SERINC2Serine incorporator 2Predicted membrane proteins
Endometrial cancer: 1.69e-7
Liver cancer: 2.11e-4
Lung cancer: 5.70e-4
Mixed
HMG20BHigh mobility group 20BPredicted intracellular proteins
Transcription factors
NucleoplasmEndometrial cancer: 1.72e-7
Urothelial cancer: 2.89e-5
Expressed in all
CD3DCD3d molecule, delta (CD3-TCR complex)CD markers
Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Endometrial cancer: 1.73e-7
Renal cancer: 3.07e-5
Cervical cancer: 8.46e-5
Head and neck cancer: 1.70e-4
Breast cancer: 3.00e-4
Urothelial cancer: 6.16e-4
Tissue enhanced
CDKN2ACyclin-dependent kinase inhibitor 2ACancer-related genes
Disease related genes
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
NucleoliEndometrial cancer: 1.82e-7
Renal cancer: 5.76e-7
Liver cancer: 2.17e-4
Head and neck cancer: 5.19e-4
Mixed
CCDC159Coiled-coil domain containing 159Predicted intracellular proteins
Nucleoplasm
Nuclear bodies
Cytosol		Endometrial cancer: 1.87e-7
Pancreatic cancer: 1.42e-4
Urothelial cancer: 8.62e-4
Ovarian cancer: 9.46e-4
Expressed in all
KIAA1324KIAA1324Predicted membrane proteins
Predicted secreted proteins
Plasma membraneEndometrial cancer: 2.14e-7
Lung cancer: 5.69e-5
Ovarian cancer: 2.16e-4
Mixed
CRELD2Cysteine-rich with EGF-like domains 2Predicted secreted proteins
Renal cancer: 1.34e-9
Endometrial cancer: 2.42e-7
Expressed in all
IER5Immediate early response 5Predicted intracellular proteins
Nucleus
Nucleoli		Endometrial cancer: 2.42e-7
Lung cancer: 1.18e-4
Renal cancer: 2.36e-4
Mixed
RNF44Ring finger protein 44Predicted intracellular proteins
NucleoplasmEndometrial cancer: 2.57e-7
Liver cancer: 8.45e-4
Expressed in all
LRRN2Leucine rich repeat neuronal 2Predicted membrane proteins
Endoplasmic reticulumEndometrial cancer: 2.59e-7
Tissue enhanced
TRIM46Tripartite motif containing 46Predicted intracellular proteins
Intermediate filaments
Cytosol		Endometrial cancer: 2.61e-7
Tissue enhanced
SAMM50SAMM50 sorting and assembly machinery componentPredicted intracellular proteins
Transporters
MitochondriaRenal cancer: 4.43e-8
Endometrial cancer: 2.63e-7
Expressed in all
TRPM4Transient receptor potential cation channel, subfamily M, member 4Disease related genes
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Nucleoplasm
Plasma membrane		Renal cancer: 2.53e-7
Endometrial cancer: 2.88e-7
Mixed
ARL4CADP-ribosylation factor-like 4CPredicted intracellular proteins
Plasma membrane
Cytosol		Renal cancer: 3.69e-8
Endometrial cancer: 2.90e-7
Urothelial cancer: 6.99e-5
Mixed
NUAK2NUAK family, SNF1-like kinase, 2Enzymes
Predicted membrane proteins
Nucleus
Nucleoli fibrillar center
Cytosol		Endometrial cancer: 3.01e-7
Pancreatic cancer: 7.94e-6
Mixed

Page of 33 | next »

Contact

The Project

The Human Protein Atlas

The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg foundation.